The fact
Discussions focus on validity of regulatory approvals obtained.
Stock remains volatile amid persistent investor doubts.
Click the link to read an article on the topic:
Discussions focus on validity of regulatory approvals obtained.
Stock remains volatile amid persistent investor doubts.